These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34193468)

  • 1. Patient disease knowledge, attitudes and behaviours related to non-alcoholic fatty liver disease: a qualitative study.
    Tincopa MA; Wong J; Fetters M; Lok AS
    BMJ Open Gastroenterol; 2021 Jun; 8(1):. PubMed ID: 34193468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and enabling factors in weight management of patients with nonalcoholic fatty liver disease: A qualitative study using the COM-B model of behaviour.
    Gu Y; Zhou R; Kong T; Zhang W; Chen Y; Wang C; Shi J; Hu Y
    Health Expect; 2023 Feb; 26(1):355-365. PubMed ID: 36385729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Focus on diet quality': a qualitative study of clinicians' perspectives of use of the Mediterranean dietary pattern for non-alcoholic fatty liver disease.
    Mayr HL; Kelly JT; Macdonald GA; Hickman IJ
    Br J Nutr; 2022 Oct; 128(7):1220-1230. PubMed ID: 33766176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility and acceptability of an evidence-informed digital intervention to support self-management in people with non-alcoholic fatty liver disease: protocol for a non-randomised feasibility study (VITALISE).
    Avery L; Smith H; McPherson S; Hallsworth K
    Pilot Feasibility Stud; 2023 Apr; 9(1):62. PubMed ID: 37076916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceived barriers and facilitators for adherence to lifestyle prescription: Perspective of obese patients with non alcoholic fatty liver disease from north India.
    Arora C; Malhotra A; Ranjan P; Vikram NK; Dwivedi SN; Singh N; Shalimar
    Diabetes Metab Syndr; 2021; 15(4):102138. PubMed ID: 34186359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital Intervention With Lifestyle Coach Support to Target Dietary and Physical Activity Behaviors of Adults With Nonalcoholic Fatty Liver Disease: Systematic Development Process of VITALISE Using Intervention Mapping.
    Hallsworth K; McPherson S; Anstee QM; Flynn D; Haigh L; Avery L
    J Med Internet Res; 2021 Jan; 23(1):e20491. PubMed ID: 33448929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical activity in pregnant women with Class III obesity: A qualitative exploration of attitudes and behaviours.
    Denison FC; Weir Z; Carver H; Norman JE; Reynolds RM
    Midwifery; 2015 Dec; 31(12):1163-7. PubMed ID: 26365374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Left to my own devices, I don't know": using theory and patient-reported barriers to move from physical activity recommendations to practice.
    Ziebart C; McArthur C; Lee L; Papaioannou A; Laprade J; Cheung AM; Jain R; Giangregorio L
    Osteoporos Int; 2018 May; 29(5):1081-1091. PubMed ID: 29441402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding Primary Care Physician Perspectives on the Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: A Qualitative Study.
    Heredia NI; John JC; Singh S; Hwang JP; Strong LL; Balakrishnan M; McNeill LH
    Inquiry; 2024; 61():469580241241272. PubMed ID: 38529894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
    Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
    J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors influencing adherence to lifestyle prescriptions among patients with nonalcoholic fatty liver disease: A qualitative study using the health action process approach framework.
    Wang L; Zhou H; Liu Y; Wang X; Yan W; Zhang J; Ren H
    Front Public Health; 2023; 11():1131827. PubMed ID: 37006574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Readiness for behaviour change in non-alcoholic fatty liver disease: implications for multidisciplinary care models.
    Stewart KE; Haller DL; Sargeant C; Levenson JL; Puri P; Sanyal AJ
    Liver Int; 2015 Mar; 35(3):936-43. PubMed ID: 24521540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention.
    Glass L; Asefa H; Volk M; Lok AS; Tincopa MA
    Dig Dis Sci; 2022 Jun; 67(6):2123-2133. PubMed ID: 34043121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical activity support or weight loss counseling for nonalcoholic fatty liver disease?
    Montesi L; Caselli C; Centis E; Nuccitelli C; Moscatiello S; Suppini A; Marchesini G
    World J Gastroenterol; 2014 Aug; 20(29):10128-36. PubMed ID: 25110440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding factors influencing uptake of healthy lifestyle practices among adults following a community cardiovascular disease prevention programme in Mukono and Buikwe districts in Uganda: A qualitative study.
    Ndejjo R; Musinguzi G; Nuwaha F; Bastiaens H; Wanyenze RK
    PLoS One; 2022; 17(2):e0263867. PubMed ID: 35176069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An internet-based approach for lifestyle changes in patients with NAFLD: Two-year effects on weight loss and surrogate markers.
    Mazzotti A; Caletti MT; Brodosi L; Di Domizio S; Forchielli ML; Petta S; Bugianesi E; Bianchi G; Marchesini G
    J Hepatol; 2018 Nov; 69(5):1155-1163. PubMed ID: 30290973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease.
    Stine JG; Soriano C; Schreibman I; Rivas G; Hummer B; Yoo E; Schmitz K; Sciamanna C
    Dig Dis Sci; 2021 Oct; 66(10):3604-3611. PubMed ID: 33098023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative study of self-management experiences in people with non-alcoholic fatty liver disease.
    Jang Y; Lee JY; Kim SU; Kim B
    Nurs Open; 2021 Nov; 8(6):3135-3142. PubMed ID: 34405583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a Pilot Structured Mobile Technology Based Lifestyle Intervention for Patients with Nonalcoholic Fatty Liver Disease.
    Tincopa MA; Lyden A; Wong J; Jackson EA; Richardson C; Lok AS
    Dig Dis Sci; 2022 Feb; 67(2):481-491. PubMed ID: 33939147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care.
    Gracen L; Hayward KL; Aikebuse M; Williams S; Russell A; O'Beirne J; Powell EE; Valery PC
    Diabet Med; 2022 Jun; 39(6):e14799. PubMed ID: 35100462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.